Carl Zeiss Meditec AG Cash Flow-to-Debt Ratio
Carl Zeiss Meditec AG cash flow-to-debt ratio. Carl Zeiss Meditec AG (AFX) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of €144.16 Million could theoretically repay 0% of its total liabilities (€1.28 Billion) in one year. Check Carl Zeiss Meditec AG investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Carl Zeiss Meditec AG (2014–2025)
Cash flow-to-debt ratio of Carl Zeiss Meditec AG from 2014 to 2025. Historical debt coverage capacity for Carl Zeiss Meditec AG across 12 annual periods. Check AFX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Carl Zeiss Meditec AG Cash Flow-to-Debt Ratio by Year (2014–2025)
Carl Zeiss Meditec AG cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Carl Zeiss Meditec AG. For the full cash flow conversion analysis, see AFX operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | €209.86 Million | €1.28 Billion | ▼ -11.1% |
| 2024 | 0.19x | €247.32 Million | €1.34 Billion | ▼ -36.6% |
| 2023 | 0.29x | €250.86 Million | €860.02 Million | ▲ +22.9% |
| 2022 | 0.24x | €188.20 Million | €792.73 Million | ▼ -53.0% |
| 2021 | 0.50x | €362.66 Million | €718.59 Million | ▲ +59.1% |
| 2020 | 0.32x | €178.53 Million | €562.73 Million | ▼ -12.6% |
| 2019 | 0.36x | €219.63 Million | €605.17 Million | ▼ -32.6% |
| 2018 | 0.54x | €187.21 Million | €347.42 Million | ▲ +444.6% |
| 2017 | 0.10x | €37.73 Million | €381.37 Million | ▼ -64.9% |
| 2016 | 0.28x | €111.77 Million | €396.57 Million | ▲ +69.8% |
| 2015 | 0.17x | €56.74 Million | €341.84 Million | ▼ -25.1% |
| 2014 | 0.22x | €63.10 Million | €284.88 Million | — |